Evidence map›Paper›PMID 30519347›Full record

ArticleJournal of Cancer2018

Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines.

Karolina Sterzyńska, Andrzej Klejewski, Karolina Wojtowicz, Monika Świerczewska, Michał Nowicki, Jacek Brązert, Radosław Januchowski

Abstract read
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Effect ofInternational journal of molecular sciences · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karolina SterzyńskaDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Andrzej KlejewskiDepartment of Nursing, Poznan University of Medical Sciences, Poznań, Poland.
Karolina WojtowiczDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Monika ŚwierczewskaDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Michał NowickiDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Jacek BrązertDepartment of Obstetrics and Women's Diseases, Poznan University of Medical Sciences, Poznań, Poland.
Radosław JanuchowskiDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

myotilinovarian cancertopotecan resistance

Identifiers

PMID30519347
PMCPMC6277650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.